Trials / Completed
CompletedNCT02463318
The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the gene expression and activity of SIRT1, and forkhead box O3 pathway by means of investigating target genes MnSOD and catalase in multiple sclerosis and healthy subjects. Also, we investigate the effect of melatonin on interaction between SIRT1 activity and target genes MnSOD and catalase in multiple sclerosis and healthy subject .Additionally, we evaluate effect the probable effect of melatonin treatment on gene expression and activity of above-mentioned genes in peripheral blood mononuclear cells of healthy subjects-treated with H2O2.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Melatonin | Melatonin is used for healthy subjects and multiple sclerosis patients |
| OTHER | Hydrogen peroxide | Hydrogen peroxide is only used for healthy subjects |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2015-06-01
- Completion
- 2015-09-01
- First posted
- 2015-06-04
- Last updated
- 2017-05-02
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT02463318. Inclusion in this directory is not an endorsement.